Fast-Tracking A COVID-19 Vaccine Could Be A Double-Edged Sword

Outlet: KUNC Radio

KUNC Radio: “You’re asking the question: Is the material safe? That is the primary emphasis of phase one trials, not whether or not it actually works or is efficacious, but whether or not the product is safe,” said Ray Goodrich, who directs the Infectious Disease Research Center at Colorado State University.